Emerging iron biomarkers — hepcidin, soluble transferrin receptor, zinc protoporphyrin, and reticulocyte hemoglobin content — are being positioned as complementary or superior alternatives to TIBC for specific iron status assessment applications, with the Total Iron Binding Capacity Reagent Market reflecting new biomarker competition for TIBC's established role in iron status...